author-photo

Sabine Junge

2

Papers

2

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer: Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase 2 trial of the German Gastric Group of the AIO.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)